Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1

Conditions

Signs and Symptoms 1Sexuality 1Sexual Dysfunction, Physiological 1Hematologic Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Sexual Health × Clear all
NCT05222282 2023-09-28

Sexual Health in Patients With Hematologic Malignancies

Rigshospitalet, Denmark

Phase NA Unknown
110 enrolled
OtherOther hematologic neoplasm

Sexual Dysfunction, Physiological, Signs and Symptoms, Hematologic Neoplasms, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡